Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Carbazochrome sodium sulfonate
Cat. No.:
0225LY-1209
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Carbazochrome sodium sulfonate is an antihemorrhagic medication used primarily for the treatment of hemorrhoids.
Synonym:
AC-17; 51460-26-5; Adenaron; Carbazon; Emex; Donaseven; Odanon; Tazin; AC 17; Auzei; Carbazochrome (sodium sulfonate); Sodium (Z)-5-(2-carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate; Carbazochrome sodium sulfonate (AC-17), sodium; 5-(carbamoyldiazenyl)-6-hydroxy-1-methyl-2,3-dihydroindole-2-sulfonate; Carbazochrome sodium sulphonate; Sodium salt of 5,6-dihydro-1-methyl-5,6-dioxo-3-indoline sulfonic acid 5-semicarbazone; 1H-Indole-2-sulfonic acid, 5-((aminocarbonyl)hydrazono)-2,3,5,6-tetrahydro-1-methyl-6-oxo-, monosodium salt; Adrenochrome sulfonate AC 17; Carnamid; Golcort; Hobat; Stopem; Sodium 5-(2-carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate; 1H-Indole-2-sulfonic acid,5-[(aminocarbonyl)hydrazono]-2,3,5,6-tetrahydro-1-methyl-6-oxo-,monosodium salt; Carbazochrome sodium sulfonate(AC-17)
CAS No.:
51460-26-5
Compound CID:
135705561
Formula:
C10H11N4NaO5S
Formula Weight:
322.03
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Carbazochrome sodium sulfonate can be used in hematological studies to investigate the enhancement of capillary resistance and the reduction of bleeding time.
Library Information
Target:
Adrenergic receptor
Receptor:
GPCR
Pathways:
Neuronal signaling; GPCR/G protein signaling
Plate Number:
AOCL-16
Plate Location:
e6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
12 mg/mL; 37.26 mM
Water Max Solubility:
3 mg/mL; 9.32 mM
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)





